---
document_datetime: 2024-08-01 12:26:18
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cabazitaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: cabazitaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.9981803
conversion_datetime: 2025-12-28 14:23:12.406615
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cabazitaxel Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                         | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0010               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                              | 30/07/2024                          |                                             | PL                               |           |
| IB/0009              | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation | 30/10/2023                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0008           | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                             | 01/08/2023   | n/a        |                        |                                                                                                                                          |
|-------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0007           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 27/07/2023   | 28/06/2024 | SmPC and PL            |                                                                                                                                          |
| IB/0005           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                               | 29/06/2023   | 28/06/2024 | SmPC                   |                                                                                                                                          |
| IA/0006           | B.II.e.3.b - Change in test procedure for the immediate packaging of the finished product - Other changes to a test procedure (including replacement or addition)                                                                                            | 12/05/2023   | n/a        |                        |                                                                                                                                          |
| IB/0004           | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                | 11/01/2023   | n/a        |                        |                                                                                                                                          |
| PSUSA/476/2 02106 | Periodic Safety Update EU Single assessment - cabazitaxel                                                                                                                                                                                                    | 24/02/2022   | 24/05/2022 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/476/202106. |
| IB/0003           | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference                                                                                                               | 29/03/2022   | 24/05/2022 | SmPC, Labelling and PL |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|         | product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH   |            |            |                 |
|---------|-----------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|
| IA/0002 | A.7 - Administrative change - Deletion of manufacturing sites                                                   | 26/01/2022 | 24/05/2022 | Annex II and PL |